Octapharma AG products

Albunorm® is a purified human albumin solution for maintenance of circulating blood volume.

Fibryga® is a highly purified and pathogen inactivated human fibrinogen concentrate and an effective and convenient treatment for fibrinogen deficiency. Fibryga offers a number of benefits: concentration is standardised; it is stable at room temperature, can be reconstituted within minutes, and has a low infusion volume; there is no need for thawing or cross-matching blood type and it is double pathogen inactivated.

Atenativ is a human antithrombin III concentrate (AT III) for the treatment of patients with congenital antithrombin deficiency.

Liquid, ready-to-use subcutaneous immunoglobulin (SCIg).

Liquid, ready-to-use subcutaneous immunoglobulin (SCIg).

octagam® 5% (50 mg/ml), Human Normal Immunoglobulin. octagam® 10% (100 mg/ml), Human Normal Immunoglobulin. Liquid, ready-to-use intravenous immunoglobulin (IVIg).

Liquid, ready-to-use intravenous immunoglobulin (IVIg). Indication: To treat patients that require replacement of antibodies to help provide protection against some infections. For treatment of some autoimmune disorders (diseases where the immune system is overactive).  Panzyga® can only be obtained on a doctor’s prescription.

Human coagulation factor VIII produced in a human cell line by recombinant DNA technology. No animal or human derived materials are added during the manufacturing process or to the final medicinal product.

Plasma-derived human factor IX concentrate.

Contains von Willebrand factor and factor VIII in a 1:1 activity ratio. Indication: Indicated for the prevention and treatment of haemorrhage or surgical bleeding in von Willebrand disease (VWD), when desmopressin (DDAVP) alone is ineffective or contra-indicated, and for the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).